PRESS RELEASE published on 02/03/2026 at 07:30, 3 months 16 days ago 2025 business update and highlights of the 2nd half: annual revenue x2, new customers signed and refocusing of the development strategy Lhyfe doubled its 2025 revenue to €9.8m by expanding client portfolio and increasing deliveries. Key projects include new offtake contracts and site constructions. ESG rating improved to 88/100 Revenue Growth ESG Rating Lhyfe Offtake Contracts Site Construction
PRESS RELEASE published on 02/03/2026 at 07:29, 3 months 16 days ago Publicis Groupe : Résultats annuels 2025
PRESS RELEASE published on 02/03/2026 at 07:29, 3 months 16 days ago Publics Groupe: Full Year 2025 Results
PRESS RELEASE published on 02/03/2026 at 07:25, 3 months 16 days ago Elevating Trust: Fox ESS Grand Gala 2026 Welcomes Over 300 Global Partners Fox ESS hosted the Grand Gala 2026, welcoming over 300 global partners to explore clean energy and strengthen collaborations. Remarkable growth and market achievements Sustainable Future Clean Energy Global Partnerships Fox ESS Grand Gala 2026
PRESS RELEASE published on 02/03/2026 at 07:15, 3 months 16 days ago Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives Sartorius Stedim Biotech réalise une croissance rentable en 2025 avec un chiffre d'affaires en hausse de 9,6 %. Perspectives positives pour 2026 Chiffre D'affaires Sartorius Stedim Biotech Croissance Rentable Perspectives 2026
PRESS RELEASE published on 02/03/2026 at 07:00, 3 months 16 days ago Siltronic AG with preliminary financial figures: Targets for 2025 achieved despite challenging conditions Siltronic AG achieves 2025 targets with preliminary financial figures despite challenging conditions. Sales at EUR 1,347 million with 4.7% decline. EBITDA margin reaches 23.5% EBITDA Margin Preliminary Financial Figures Sales Decline Siltronic AG 2025 Targets
PRESS RELEASE published on 02/03/2026 at 07:00, 3 months 16 days ago Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives Sartorius Stedim Biotech réalise une croissance rentable en 2025 et maintient des perspectives positives. Chiffre d'affaires en hausse de 9,6% à taux de change constants. EBITDA à 914 millions d'euros. Perspectives de croissance rentable pour 2026 Chiffre D'affaires EBITDA Sartorius Stedim Biotech Croissance Rentable Perspectives Positives
PRESS RELEASE published on 02/03/2026 at 07:00, 3 months 16 days ago Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook Sartorius Stedim Biotech achieves significant profitable growth in 2025 with unaudited sales revenue up 9.6% in constant currencies. Management expects continued growth in 2026 Financial Results Sartorius Stedim Biotech Profitable Growth 2025 2026
PRESS RELEASE published on 02/03/2026 at 07:00, 3 months 16 days ago Medacta Group SA: Medacta Group reports continued significant above-market revenue growth of 18.5% in constant currency in 2025 Medacta Group SA reports 18.5% revenue growth in 2025, with strong performance in all geographic markets and business lines. New jobs created to drive further expansion Revenue Growth Business Lines Medacta Group SA 2025 Geographic Markets
PRESS RELEASE published on 02/03/2026 at 07:00, 3 months 16 days ago Sartorius achieves considerable profitable growth in 2025 and maintains positive outlook Sartorius achieves considerable profitable growth in 2025 with a 7.6% increase in sales revenue to around 3.5 billion euros. Positive outlook maintained for 2026 Sartorius Profitable Growth Sales Revenue Positive Outlook 2026
Published on 05/20/2026 at 00:00, 1 hour 49 minutes ago Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Published on 05/19/2026 at 19:45, 6 hours 4 minutes ago Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative
Published on 05/19/2026 at 16:47, 9 hours 2 minutes ago Lithium South Re-Schedules Plan of Arrangement Closing as a Result of Cease Trade Order
Published on 05/19/2026 at 15:15, 10 hours 34 minutes ago Loop Industries Secures Gujarat Government Alignment Supporting First Commercial Deployment and Multi-Phase India Expansion
Published on 05/19/2026 at 15:00, 10 hours 49 minutes ago Jaguar Health Announces Active Treatment Only Continuation of Pivotal Multicenter Clinical Trial in Pediatric Patients with Microvillus Inclusion Disease (MVID) to Support a New Drug Application (NDA) for Liquid Oral Crofelemer
Published on 05/19/2026 at 21:24, 4 hours 24 minutes ago EQS-Adhoc: ams OSRAM announces the successful pricing of EUR 1 billion 7.250% Senior Notes due 2032, supporting the path to positive Free Cash Flow from 2027 onwards
Published on 05/19/2026 at 19:50, 5 hours 59 minutes ago EQS-Adhoc: fox e-mobility AG: 3 convertible bonds issued
Published on 05/19/2026 at 19:40, 6 hours 9 minutes ago PRC-Saltillo Named to Forbes Accessibility 200 List
Published on 05/19/2026 at 19:05, 6 hours 44 minutes ago Casper Ruud Returns to Stockholm as Bybit EU Expands Across the Nordics
Published on 05/19/2026 at 18:56, 6 hours 52 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/19/2026 at 18:34, 7 hours 14 minutes ago Availability of preparatory documents for the annual general meeting to be held on June 9, 2026
Published on 05/19/2026 at 18:34, 7 hours 14 minutes ago Mise à disposition des documents préparatoires à l’assemblée générale annuelle mixte des actionnaires du 9 juin 2026
Published on 05/19/2026 at 18:30, 7 hours 18 minutes ago TERACT- Communiqué InVivo Group - Retrait obligatoire